Literature DB >> 2872909

gamma-Glutamyltranspeptidase activity in human breast lesions: an unfavourable prognostic sign.

S Bard, P Noël, F Chauvin, G Quash.   

Abstract

The activity of gamma-glutamyltranspeptidase (gamma GT) (EC 2.3.2.2) was examined by histoenzymatic labelling on frozen sections derived from normal breast tissue, benign lesions and carcinomas. In biopsies from normal tissue and benign lesions, labelling was very intense in lumina and in the apical pole of the cells lining the lumina whilst in the cytoplasm it was slightly positive. In 34 out of 70 carcinomas, gamma GT activity was either undetectable or slightly positive while in the remaining 36 there was intense activity. Statistical examination of the results revealed no obvious correlation of gamma GT activity with histological grade of the tumour, progesterone receptor content or classification of patients by pre- or postmenopausal status. A good correlation between gamma GT activity and the following unfavourable prognostic signs: lymph node metastases and absence of oestradiol receptors. Patients with gamma GT-negative tumours may have a more favourable prognosis than those with gamma GT-positive tumours.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2872909      PMCID: PMC2001394          DOI: 10.1038/bjc.1986.107

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  28 in total

1.  Localization and significance of gamma-glutamyltranspeptidase in normal and neoplastic mouse skin.

Authors:  L M De Young; W L Richards; W Bonzelet; L L Tsai; R K Boutwell
Journal:  Cancer Res       Date:  1978-11       Impact factor: 12.701

2.  Gamma-glutamyltranspeptidase activity and cyclic AMP levels in rat liver and mammary gland during the lactogenic cycle and in the oestradiol-progesterone pseudo-induced pregnancy.

Authors:  J Puente; M A Varas; G Beckhaus; M Sapag-Hagar
Journal:  FEBS Lett       Date:  1979-03-01       Impact factor: 4.124

3.  Liver metastases found by follow-up of patients operated on for colorectal cancer.

Authors:  O Almersjö; S Bengmark; L Hafström
Journal:  Cancer       Date:  1976-03       Impact factor: 6.860

4.  Differences in the isoelectric focusing patterns of gamma-glutamyl transpeptidase from normal and cancerous rat mammary tissue.

Authors:  S Jaken; M Mason
Journal:  Proc Natl Acad Sci U S A       Date:  1978-04       Impact factor: 11.205

5.  Gamma-glutamyltransferase in putative premalignant liver cell populations during hepatocarcinogenesis.

Authors:  R Cameron; J Kellen; A Kolin; A Malkin; E Farber
Journal:  Cancer Res       Date:  1978-03       Impact factor: 12.701

6.  Serine-borate complex as a transition-state inhibitor of gamma-glutamyl transpeptidase.

Authors:  S S Tate; A Meister
Journal:  Proc Natl Acad Sci U S A       Date:  1978-10       Impact factor: 11.205

7.  Estrogen receptor as an independent prognostic factor for early recurrence in breast cancer.

Authors:  W A Knight; R B Livingston; E J Gregory; W L McGuire
Journal:  Cancer Res       Date:  1977-12       Impact factor: 12.701

8.  Glutathione and gamma glutamyl transpeptidase in rat liver during chemical carcinogenesis.

Authors:  S Fiala; A Mohindru; W G Kettering; A E Fiala; H P Morris
Journal:  J Natl Cancer Inst       Date:  1976-09       Impact factor: 13.506

9.  Prognostic value of estrogen receptor determinations in patients with breast cancer.

Authors:  M A Rich; P Furmanski; S C Brooks
Journal:  Cancer Res       Date:  1978-11       Impact factor: 12.701

10.  The contribution of serum enzymes and carcinoembryonic antigen to the early diagnosis of metastatic colorectal cancer.

Authors:  E H Cooper; R Turner; L Steele; A M Neville; A M Mackay
Journal:  Br J Cancer       Date:  1975-01       Impact factor: 7.640

View more
  6 in total

1.  Redox-Mediated Suberoylanilide Hydroxamic Acid Sensitivity in Breast Cancer.

Authors:  Ferdinando Chiaradonna; Iros Barozzi; Claudia Miccolo; Gabriele Bucci; Roberta Palorini; Lorenzo Fornasari; Oronza A Botrugno; Giancarlo Pruneri; Michele Masullo; Alfonso Passafaro; Viviana E Galimberti; Valeria R Fantin; Victoria M Richon; Salvatore Pece; Giuseppe Viale; Pier Paolo Di Fiore; Giulio Draetta; Pier Giuseppe Pelicci; Saverio Minucci; Susanna Chiocca
Journal:  Antioxid Redox Signal       Date:  2015-05-27       Impact factor: 8.401

Review 2.  Gamma-glutamyl transpeptidase: redox regulation and drug resistance.

Authors:  Marie H Hanigan
Journal:  Adv Cancer Res       Date:  2014       Impact factor: 6.242

Review 3.  Glutathione S-conjugates as prodrugs to target drug-resistant tumors.

Authors:  Emma E Ramsay; Pierre J Dilda
Journal:  Front Pharmacol       Date:  2014-08-11       Impact factor: 5.810

4.  Involvement of tumor macrophage HIFs in chemotherapy effectiveness: mathematical modeling of oxygen, pH, and glutathione.

Authors:  Duan Chen; Andrey A Bobko; Amy C Gross; Randall Evans; Clay B Marsh; Valery V Khramtsov; Timothy D Eubank; Avner Friedman
Journal:  PLoS One       Date:  2014-10-08       Impact factor: 3.240

Review 5.  Role of glutathione in cancer progression and chemoresistance.

Authors:  Nicola Traverso; Roberta Ricciarelli; Mariapaola Nitti; Barbara Marengo; Anna Lisa Furfaro; Maria Adelaide Pronzato; Umberto Maria Marinari; Cinzia Domenicotti
Journal:  Oxid Med Cell Longev       Date:  2013-05-20       Impact factor: 6.543

6.  Glutathione localisation in benign and malignant human breast lesions.

Authors:  G I Murray; M D Burke; S W Ewen
Journal:  Br J Cancer       Date:  1987-06       Impact factor: 7.640

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.